Special Issue "Hormone Receptors in Genitourinary Tumors"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 May 2018) | Viewed by 24409
Interests: nuclear hormone receptors; androgen receptor; glucocorticoid receptor; antiandrogens; glucocorticoids; urothelial cancer; prostate cancer; genitourinary pathology
Special Issues, Collections and Topics in MDPI journals
Topical Collection in Cells: Functions of Nuclear Receptors
Topical Collection in Cells: Feature Papers in Cell Nuclei: Function, Transport and Receptors
Special Issue in Cells: 10th Anniversary of Cells—Advances in Cell Nuclei: Function, Transport and Receptors
Special Issue in International Journal of Molecular Sciences: Sex Hormone Receptor Signals in Human Malignancies 2.0
Special Issue in Cells: The Role of Androgen Receptor in Prostate Cancer—Revisited
Hormone receptors that bind to specific hormones are known to have widespread physiological functions. Recently, a large body of evidence has emerged suggesting that hormone receptors play a role in the development and progression of various types of malignancies, although their exact functions are not fully characterized. The aim of this Special Issue is to provide an overview of current preclinical and clinical findings indicating the involvement of hormone receptor signals in genitourinary tumors including prostate cancer, as well as renal cancer, upper urinary tract cancer, bladder cancer, and testicular cancer that have not traditionally been considered as endocrine neoplasms. Original research or review articles on signaling related to any hormone receptors in urological tumors would be most welcome.
Prof. Dr. Hiroshi Miyamoto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- androgen receptor
- estrogen receptor
- glucagon receptor
- glucocorticoid receptor
- gonadotropin receptors
- luteinizing receptor
- progesterone receptor
- orphan receptor
- retinoid receptor
- somatostatin receptor
- vitamin D receptor
- prostate cancer
- renal cancer
- testicular cancer
- urothelial cancer